578 Results (Page 17 of 24)
Canada Markets Research Reports
Canada Multiple Sclerosis Drugs Market Analysis
Canada Multiple Sclerosis Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Multiple sclerosis is rising due to increase in Incidence and prevalence of multiple sclerosis (MS), Improved diagnosis and awareness, advancements in healthcare infrastructure , Advancements in Treatment Options, Expanding Pipeline of Innovative Therapies, technological advancements and increase in funding for research of multiple sclerosis. Major global players in Multiple Sclerosis Drugs Market are Abbott (U.S.), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Takeda Pharmaceutical Company Limited (Japan), Jazz Pharmaceuticals, Inc. (U.K.), Novartis AG (Switzerland), Biora Therapeutics, Inc. (U.S.), Bausch Health Companies Inc. (Canada), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Mylan N.V. (U.S.)
Canada Myasthenia Gravis Drugs Market Analysis
Canada Myasthenia Gravis Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for myasthenia gravis is rising due to increasing prevalence and incidence of disease, improved diagnostic techniques, increased awareness and better understanding of the disease, Supportive Government Initiatives like providing financial support, improving healthcare infrastructure, promoting research in rare diseases and Technological Advancements in drugs and therapies treating myasthenia gravis. Major global players in Myasthenia Gravis Drugs Market are Alexion Pharmaceuticals, Inc., Bausch Health Companies, Inc., Novartis AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Avadel, Dr. Reddy's Laboratories, Ltd., Fresenius Kabi, AG, Endo Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc., Mylan N.V., Aurobindo Pharma, Pfizer, Inc., Astellas Pharma, Inc.
Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Drugs Market Analysis
Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Increasing awareness and diagnosis, Increasing funding for medical infrastructure and high rate of multiple sclerosis prevalence (MS), unmet medical needs, advancements in drug development, Regulatory Approvals of drugs like eculizumab, inebilizumab and satralizumab , rising healthcare expenditure and growing collaborations in research and development of drugs are the major drivers for Neuromyelitis Optica Spectrum Disorder (NMOSD) drugs Market. Major global players in Neuromyelitis Optica Spectrum Disorder (NMOSD) drugs Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Zydus Cadila (India), Boehringer Ingelheim International GmbH. (Germany), Apotex Inc. (Canada), AstraZeneca (U.K.), Horizon Therapeutics PLC (Ireland), Johnson & Johnson Private Limited (U.S.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), LEO Pharma A/S (Denmark).
Canada POMC Genetic Obesity Drugs Market Analysis
Canada POMC Genetic Obesity Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for POMC Genetic Obesity Drugs is growing due to increase spending in research and development activities by pharmaceutical companies, introduction of new emerging therapies like gene editing and gene replacement approaches, incentives provided by regulatory body?s in the form of orphan drug designations. Novo Nordisk A/S , rhythm Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated ,Amgen Inc are the key market players operating in global POMC genetic obesity drugs market.
Canada Pompe Disease Drugs Market Analysis
Canada Pompe Disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Pompe disease Drugs is growing due to increase in awareness about the disease , better diagnosis, advancements in treatment options and increase in research and development activities by different pharmaceutical companies and research organizations. Sanofi Genzyme ,BioMarin Pharmaceutical Inc., Avrobio Inc., Amicus Therapeutics Inc. are the key market players operating in global pompe disease market.
Canada Medical Devices Market Analysis
This report presents a strategic analysis of the Canada Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Medical Devices Market, offering unmatched value, accuracy and expert insights.
Canada Alzheimer's Disease Diagnostics Market Analysis
Canada Alzheimer's Disease Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Alzheimer's disease diagnostics is expanding as a result of rising healthcare spending in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of Alzheimer's disease. Some of the key players in the global Alzheimer's Disease Diagnostics Market include Biogen, Eli Lilly and Company, Roche, Merck & Co., GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujirebio, Cogstate, and Advanced Brain Monitoring.
Canada Ambulance Service Market Analysis
Canada Ambulance Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ambulance Service is expanding as a result of rising incidence of traumatic accidents and medical tourism in both developed and developing nations. This demand is fueling the development of better infrastructure and services for timely diagnosis and treatment while transportation of patient from one place to healthcare facilities. Some of the key players in the global Ambulance Service Market include Babcock International Group PLC, Acadian Ambulance Service, BVG India Limited, America Ambulance Service, Inc., Falck A/S, Air Methods Corporation, Ziqitza Health Care Limited, Harmonie Ambulance, Envision Healthcare, and Medivic Aviation.
Canada Ambulatory Surgery Center Market Analysis
Canada Ambulatory Surgery Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ambulatory Surgery Center is expanding as a result of Increasing demand for minimal invasive surgeries and rising healthcare expenditure. This demand is fueling the development of better surgical devices and methods for effective and accurate outcomes of ambulatory surgeries. Some of the key players in the global ambulatory surgery center market include Community Health Systems, Inc.; Envision Healthcare Corporation; Terveystalo; Tenet Healthcare Corporation; MEDNAX Services, Inc.; TeamHealth; Quorum Health Corporation; UnitedHealth Group; Surgery Partners; and Healthway Medical Group.
Canada Antimicrobial Susceptibility Testing Market Analysis
Canada Antimicrobial Susceptibility Testing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Antimicrobial Susceptibility Testing is expanding as a result of increasing infectious diseases and rising research and development funding globally. This demand is fueling the development of better tools and methods for antimicrobial susceptibility testing market. Some of the key players in the global Antimicrobial Susceptibility Testing Market include Bio-Rad Laboratories Inc.; Merck & Co., Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; BD; bioM?rieux SA; Creative Diagnostics; Hi-Media Laboratories Pvt. Ltd.; ELITechGroup; and F. Hoffmann-La Roche Ltd.
Canada Appetite (Eating) Disorder Market Analysis
Canada Appetite Disorder Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Appetite Disorder is expanding as a result of rising psychiatric illness and increasing prevalence of eating disorders. This demand is fueling the development of better medication and treatment procedures for the early intervention of appetite disorders.Some of the key players in the global Appetite Disorder Market include Bausch & Lomb Incorporated, Somerset Therapeutics, LLC, Equip, Teva Pharmaceuticals Industries Ltd, Mylan N.V., Pfizer Inc., Amneal Pharmaceutical LLC, Sun Pharmaceutical Industries Ltd, Moriah Behavioral Health, and Eli Lilly and Company.
Canada Biomaterial Wound Dressing Market Analysis
Canada Biomaterial Wound Dressing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Biomaterial Wound Dressing is expanding as a result of rising healthcare expenditure by government and the increasing burden of chronic wounds. This will create a rapid demand for Biomaterial Wound Dressing in the years to come. Some of the key players in the global Biomaterial Wound Dressing include 3M Company, Molnlycke Health Care AB, Smith & Nephew PLC, ConvaTec Group, DermaRite Industries LLC, B. Braun Melsungen AG, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medtronic PLC.
Canada Blood Gas and Electrolyte Analyzers Market Analysis
Canada Blood Gas and Electrolyte Analyzers Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Blood Gas and Electrolyte Analyzers is expanding as a result of rising geriatric population, increased number of patients in emergency rooms. This rise is fueling the growth of Blood Gas and Electrolyte Analyzers market. Some of the key players in the global Blood Gas and Electrolyte Analyzers Market include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, Convergent Technologies GmbH & Co. KG, Radiometer Medical, Medica Corporation, Siemens AG, Nova Biomedical, Sensa Core Medical Instrumentation Pvt. Ltd., Transasia Bio-Medicals Ltd., and Werfen Science SA.
Canada Body Fat Reduction Market Analysis
Canada Body Fat Reduction Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Body Fat Reduction is expanding as a result of the rise in focus on aesthetics and the increasing prevalence of obesity. This demand is fueling the development of better procedures and devices for effective and accurate body fat reduction. Some of the key players in the global Body Fat Reduction Market include Abbvie Inc. (Allergan Inc.), Apollo Hospitals Enterprise Limited (Apollo Cosmetic Clinics), Bausch Health Companies Inc. (Solta Medical International Inc.), Candela Medical, Cutera Inc., Cynosure, Llc., Lumenis Ltd., Sciton, Inc., Sisram Medical Ltd (Alma Lasers Ltd.), and Vlcc Health Care Ltd.
Canada Bone Cancer Diagnostic Market Analysis
Canada Bone Cancer Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Bone Cancer disease diagnostics is expanding as a result of rising healthcare spending in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of Bone Cancer. Some of the key players in the global Bone Cancer Diagnostics Market include Amgen, Eli Lilly and Company, Roche, Bayer AG, Novartis AG, Pfizer Inc., Merck & Co., GE Healthcare, Siemens Healthineers, and Philips Healthcare.
Canada Brain Cancer Diagnostic Market Analysis
Canada Brain Cancer Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Brain Cancer diagnostics is expanding as a result of increasing incidence of the Brain Cancer. There have been significant developments in imaging techniques such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) which are driving the growth of Brain Cancer Diagnostics market. Some of the key players in the global Brain Cancer Diagnostics Market Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics,Biocept, Inc., Koninklijke Philips N.V, Canon Medical Systems, Hitachi, Ltd., Neusoft Medical Systems.
Canada Breast Cancer Diagnostic Market Analysis
Canada Breast Cancer Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Breast Cancer diagnostics is expanding as a result of increasing prevalence of the disease worldwide. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of Breast Cancer. Some of the key players in the global Breast cancer Diagnostics Market include Sanofi, Eli Lilly and Company, Genetech, Merck & Co., Bristol Myers Squibb, AstraZeneca, Pfizer Inc., Novartis AG, GE Healthcare, Siemens Healthineers, and Philips Healthcare.
Canada Cardiovascular Diagnostic Testing Market Analysis
Canada Cardiovascular Diagnostic Testing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Cardiovascular Diagnostic Testing is expanding as a result of rising geriatric population globally and increasing prevalence of chronic heart conditions. These factors are giving boost to the development of better diagnostic tools and methods for the early detection and accurate diagnosis of cardiovascular diseases. Some of the key players in the global Cardiovascular Diagnostic Testing Market include Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., CardioDx, Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Canada Cholesterol Testing Service Market Analysis
Canada Cholesterol Testing Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Cholesterol Testing Service is expanding as a result of increasing prevalence of cardiovascular diseases and rising healthcare spending in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for the early detection and testing of Cholesterol. Some of the key players in the global Cholesterol Testing Service Market include Boston Scientific Corporation, Medtronic, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Abbott, AstraZeneca, LivaNova PLC, BIOTRONIK SE & Co. KG, ACON Laboratories, Inc., Quest Diagnostics Incorporated, Spectra Laboratories, Inc., Eurofins Scientific, and Randox Laboratories Ltd
Canada Clinical Trial Biorepository & Archiving Solutions Market Analysis
Canada Clinical Trial Biorepository & Archiving Solutions Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Clinical Trial Biorepository & Archiving Solutions is growing as a result of expanding fields of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data collection easier by using software like Laboratory Information Management System for the management of laboratory samples. Some of the key players in the global Clinical Trial Biorepository & Archiving Solutions Market include Azenta U.S., Inc., Thermo Fisher Scientific Inc., Precision for Medicine, Inc., Medpace, LabCorp Drug Development, ATCC, Q2 Solutions, Labconnect, Charles River Laboratories, Cell&Co. BioServices, and Brooks Life Science.
Canada Clinical Trial Equipments & Ancillary Solutions Market Analysis
Canada Clinical Trial Equipment & Ancillary Solutions Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Clinical Trial Equipment & Ancillary Solutions is expanding as a result of rising R&D expenditure in this sector. Increasing clinical trials, development in technology and increasing demand for personalized medicine are fueling the development of accurate clinical trial equipment and ancillary solutions market. Some of the key players in the global Clinical Trial Equipment & Ancillary Solutions Market include Thermo Fisher Scientific Inc., Covance Inc., LabCorp, Parexel International Corporation, PRA Health Sciences, Inc., ICON plc, Medpace Holdings, Inc., Syneos Health Inc., IQVIA Holdings Inc., Charles River Laboratories International, Inc.
Canada Clinical Trial Kits Market Analysis
Canada Clinical Trial Kits Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Clinical Trial Kits is expanding as a result of rising clinical trials, investment in Research & Development, and growing demand for remote services. Some of the key players in the global Clinical Trial Kits Market include Brooks Life Science, Q2 Solutions, Patheon (Thermo Fisher Scientific Inc), LabCorp Drug Development, Charles River Laboratories, LabConnect, Almac Group, Precision Medicine Group, Cerba Research, Alpha Laboratories, Marken, and Clinigen.
Canada Clinical Trial Packaging Market Analysis
Canada Clinical Trial Packaging Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Clinical Trial Packaging is expanding as a result of development of new drugs and an increase in research & development activities. Additionally, there is an increasing need for creative packaging solutions, which is encouraging the use of packaging materials that are more eco-friendly and can be recycled with ease. Such elements are fueling the expansion of the clinical trial packaging industry. Some of the key players in the global Clinial Trial Packaging Market include Bilcare, Fisher Clinical Services, Wuxi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, The Coghlan Group, Xerimis Inc., Piramal Pharma Solutions, Sentry BioPharma, Sharp Packaging, Westrock, and Corden Pharma Gmbh.
Canada Clinical Trial Planning and Design service Market Analysis
Canada Clinical Trial Planning and Design Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Clinical Trial Planning and Design Service Market is growing due to rapid increase in technological advancements, growing collaboration, and surge of vendors in the market. Some of the key players in the global Clinical Trial Planning and Design Service Market include PharmsLex, Emergo UL, Cytel, Health Policy Associate, CD BioSciences, LLX Solutions, SGS, ADM Korea, ClinAsis, BioPoint, Atlantia Clinical Trials, IQVIA, and PPD, Inc.
Canada Clinical Trial Supply & Logistics for Pharmaceutical Market Analysis
Canada Clinical Trial Supply & Logistics for Pharmaceuticals Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Clinical Trial Supply & Logistics for Pharmaceuticals Market is growing due to rapid increase in clinical trials, implementation of strict regulations, increase in research and development expenditure by pharmaceutical and biopharmaceutical firms, and advancements in technology. Some of the key players in the global Clinical Trial Supply & Logistics for Pharmaceuticals Market include Thermo Fisher Scientific (Patheon), Catalent, Inc., Parexel, Almac Group, Marken, Piramal Pharma Solutions, UDG Healthcare, DHL, FedEx, Movianto, and Packaging Coordinators Inc.
